Observations placeholder

Ultravist and Iopromide

Identifier

019905

Type of Spiritual Experience

Hallucination

Number of hallucinations: 11

Background

A description of the experience

Iopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use.

It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT) and CT pulmonary angiograms (CTPAs).

On Dec, 13, 2016 7,251 people reported to have side effects when taking Ultravist.
Among them, 4 people (0.06%) have Hallucination

On Dec, 24, 2016 1,345 people reported to have side effects when taking Ultravist 150.  Among them, 2 people (0.15%) have Hallucination

On Jan, 08, 2017 2,779 people reported to have side effects when taking Ultravist 300.  Among them, 2 people (0.07%) have Hallucination

On Jan, 08, 2017 1,333 people reported to have side effects when taking Ultravist 370.  Among them, 3 people (0.23%) have Hallucination, Visual

Time on Ultravist when people have Hallucination  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Hallucination 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

 

On Jan, 13, 2016: 6,523 people reported to have side effects when taking Ultravist. Among them, 52 people (0.80%) have Death.

Time on Ultravist when people have Death  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Death 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Gender of people who have Death when taking Ultravist  :

  Female Male
Death 61.54% 38.46%

Age of people who have Death when taking Ultravist  :

  0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Death 0.00% 0.00% 0.00% 4.35% 6.52% 17.39% 17.39% 54.35%

Top conditions involved for these people  :

  1. Computerised tomogram abdomen (15 people, 28.85%)
  2. Hepatic cirrhosis (3 people, 5.77%)
  3. Hepatic neoplasm malignant (3 people, 5.77%)
  4. Percutaneous coronary intervention (3 people, 5.77%)
  5. Computerised tomogram abnormal (2 people, 3.85%)

 On Jan, 7, 2016: 1,416 people reported to have side effects when taking Ultravist 150. Among them, 13 people (0.92%) have Death.

Time on Ultravist 150 when people have Death  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Death 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

 On Jan, 28, 2016: 2,787 people reported to have side effects when taking Ultravist 300. Among them, 14 people (0.50%) have Death.

Time on Ultravist 300 when people have Death  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Death 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

 On Jan, 5, 2016: 1,299 people reported to have side effects when taking Ultravist 370. Among them, 20 people (1.54%) have Death.

Time on Ultravist 370 when people have Death  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Death 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

 

 

 

 

The source of the experience

eHealthme

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Activities

Overloads

MRI Contrast agents

Commonsteps

References